NCT01308346View on ClinicalTrials.gov

ABSORB PHYSIOLOGY Clinical Investigation

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Coronary Artery Disease
Interventions
DEVICE

Bioabsorbable Vascular Solutions Everolimus Eluting Coronary Stent System (BVS EECSS)

Bioabsorbable Everolimus Eluting Coronary Stent

DEVICE

XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Trial Locations (6)

3084

Austin Health, Heidelberg

3168

Monash Medical Centre, Melbourne

5000

Royal Adelaide Hospital, Adelaide

168752

National Heart Centre Singapore, Singapore

Unknown

Queen Elizabeth, Hong Kong

Maasstad Ziekenhuis, Rotterdam

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY